Images
Filter
Brain drug delivery systems, allied with their characteristics for overcoming the blood-brain barrier (BBB).
The use of a single treatment in heterogeneous populations has proved problematic in clinical trials undertaken in patients with neurodegenerative diseases.
A table that provides you an overview on non-motor symptoms common in Parkinson’s disease
This image includes an analysis of 2,640 people with Parkinson’s disease looking at the various comorbidities seen in these people
One of the main challenges of treating psychotic symptoms in PD is that many antipsychotic medications have an anti-dopaminergic effect
No results matched your search.
Please try again.